Skip to main content
OpenTrials
Completed

NCT Number: NCT03647748

Effects of Green Light Therapy on Body Contouring and Cellulite

A double-blind, placebo-controlled randomized evaluation of the effect of Cellulize, a green light low level laser system for aesthetic use for the non-invasive reduction in fat layer for body contouring and reduction of cellulite.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Wunderlich Chiropractic Clinic, Cape Coral, Florida, United States

Loading trial locations.

About this study

This clinical trial will provide objective evidence showing effectiveness of the Cellulize 532nm green light therapy for the non-invasive reduction in fat layer for body contouring, and for the non-invasive treatment for the appearance of cellulite.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Study participant between the ages of 18 and older.
  • Female only
  • Subject is willing and able to abstain from partaking in any treatment other than the study procedures (existing or new) to promote body contouring/circumference reduction/weight loss during the course of study participation.
  • Subject is willing and able to maintain his or her regular (typical pre-study) diet and exercise regimen without effecting significant change in either direction during study participation.

Exclusion criteria

  • No photo-therapy (red or green) within 3 weeks of treatment.
  • Known cardiovascular disease such as cardiac arrhythmias, congestive heart failure.
  • Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers.
  • Prior surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc.
  • Medical, physical, or other contraindications for body sculpting/weight loss.
  • Current use of medication(s) known to affect weight levels/cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent.
  • Any medical condition known to affect weight levels and/or to cause bloating or swelling.
  • Active infection, open wound (e.g. sores, cuts, ulcers, burns, etc.) or other external trauma to the areas to be treated with the laser/lymphatic drainage system devices.
  • Photosensitive condition or medication.
  • Active cancer within the past year.
  • Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation.
  • Diminished ability to void waste (liver or kidneys).
  • Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.

Treatment and study plan

Sham Comparator

Device

A modified device utilizing a pigtail connector to bypass active treatment.

Primary outcomes

  1. Average Change in Inches of Total Circumference Measurements

    Time frame: 2 weeks

    Average Change in Inches of Total Circumference Measurements for effect of Cellulize, a LED 532nm green light low level laser system for aesthetic use for the non-invasive reduction in fat layer for body contouring from baseline measurements, and after treatment.

Secondary outcomes

  1. Durability of Effect

    Time frame: 2 weeks

    Durability of Effect: a term used to indicate whether the results of the primary outcome endure at the 2 week follow up time point. If the average change in inches of total circumference continues decreasing or stays the same, then the durability of effect is assumed to endure for at least two weeks. If the measurements at the 2-week time point show that the changes in inches return to previous measures at the start of treatment, then the effect is considered temporary.

  2. Change in appearance of cellulite

    Time frame: 2 weeks

    Change in appearance of cellulite is a measure of the Nurnberger-Muller Scale (NMS) from baseline to 2 weeks post-assessment for both of the right and left thighs.

Sponsors and collaborators

Lead sponsor

Ward Photonics LLC

Industry

Registry information

Acronym: Cellulize

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Aug 27, 2018
Registry last updated
Aug 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.